民謠的企業

2023年6月1日

喜歡這個故事嗎?請分享!民謠企業投資於救生設備LifeFlow®旨在幫助臨床醫生更有效且高效地交付血液和靜脈輸液危重病人。410醫療公司,達勒姆,NC-based醫療設備公司為緊急開發創新技術和急救護理,宣布完成其750萬美元的B係列融資,其中一個公司的新投資者是民謠企業。在社交媒體對其投資,約翰遜城市風險基金,民謠健康的投資機構,指出410年醫學的主要產品,LifeFlow®,開始作為一個飛行員Niswonger兒童醫院,很快就證明了“交付及時有效的複蘇病人的能力。結果讓我們擴大使用的設備設施在整個企業通過強有力的臨床領導(和)民謠健康創新中心的支持。“這輪融資,初始收盤於2022年末,由Hatteras Venture Partners的進一步參與新的和現有的投資者包括奧蘭多健康企業,民謠,催化劑由Wellstar OSF醫療、和WakeMed。LifeFlow®旨在幫助臨床醫生更有效且高效地交付血液和靜脈輸液危重病人。嚴重膿毒症影響每年有超過一百萬名成人和兒童在美國,是住院患者死亡的最常見原因。創傷患者死亡的主要原因是小於45歲。 In these and other conditions leading to hypotension and shock, rapid delivery of blood or IV fluid is a life-saving therapy, yet with traditional infusion methods, providers often fail to achieve timely resuscitation or adhere to published guidelines. Since FDA clearance in 2016, LifeFlow has been adopted at many leading healthcare systems in the U.S., including Orlando Health, Ballad Health, and Wellstar. “Incorporating this leading-edge medical device into our pediatric and emergency settings has already made a significant impact in our ability to deliver timely and effective resuscitation to patients in need, elevating their chances of survival and promoting their overall well-being,” said Amit Vashist, Chief Clinical Officer for Ballad Health and Clinical Advisor for Ballad Ventures. 410 Medical was founded in 2013. Subscribe to our newsletter